StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Pharmacyclics, Inc.

Enter Symbol or Keywords

OPS Ranking of "7" Reiteration for Pharmacyclics

Stock Quote: (NCM:PCYC)

11/16/2009

19.46

0.00

0.00%

OPS Ranking of "7" Reiteration for Pharmacyclics

Last

Price Change

% Chg

Volume

Sarasota, FL, November 16, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "7" for Pharmacyclics, Inc. (NASDAQ:PCYC). Pharmacyclics has had an OPS Ranking of "7" for two ... read full story

Website Address:	www.pcyc.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: PCYC

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: PCYC

10/01/2010

Pharmacyclics' EBITDA Hits Two Year Low

09/29/2010

Pharmacyclics' OPS Ranking Downgraded by StockDiagnostics.com

09/29/2010

Fourth Quarter Free Cash Flow Turns Negative for Pharmacyclics

... more PCYC exclusives

Other News Sources: PCYC

12/22/2011

PCYC: Drops -1.45%; Vol +52%; Last 90 Min of Trading

12/19/2011

Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent

12/14/2011

PCYC: Conference call regarding Interim Phase II Trial Results for BTK Inhibitor PCI-32765 in Mantle Cell Lymphoma at American Society of Hematology (ASH) Annual Meeting @ 16:30 ET Today

... more PCYC news from other sources

Daily Market Updates

02/06/2012

Stocks Pull Back Modestly Today from Multi-Year Highs Last Week

U.S. stocks ended modestly lower as Greece continued to overhang the markets today. Greece missed another deadline today to respond to austerity terms of a new EU/IMF bailout. Leaders of the political parties in Greece's coalition government were una ... read full story